CING Insider Trading Activity and SEC Form 4 Filings
CING insider trading summary
Over the past 12 months, insiders at Cingulate Inc. (CING) reported 5 open-market purchases worth $657K by 5 insiders and no sales on SEC Form 4. Net insider buying was $657K.
Latest CING insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 13, 2026 | Thomas Jeffrey Hargroves | Director | Buy | $490K (97,276 @ $5.04) |
| Feb 6, 2026 | Jennifer L. Callahan | SVP and CFO | Buy | $25K (4,864 @ $5.04) |
| Feb 6, 2026 | Shane J. Schaffer | Chief Executive Officer | Buy | $34K (6,809 @ $5.04) |
| Feb 6, 2026 | Peter J. Werth | Director | Buy | $98K (19,455 @ $5.04) |
| Feb 6, 2026 | Matthew Brams | EVP and Chief Medical Officer | Buy | $10K (1,946 @ $5.04) |
| Aug 15, 2024 | Laurie Myers | EVP and COO | Sell | $841 (202 @ $4.17) |
| Sep 15, 2023 | Jennifer L. Callahan | Corporate Controller | Buy | $3K (5,000 @ $0.67) |
| Aug 11, 2023 | Peter J. Werth | Director | Buy | $1.0M (1,823,155 @ $0.55) |
| May 15, 2023 | Jennifer L. Callahan | Corporate Controller | Buy | $2K (2,000 @ $1.01) |
| May 12, 2023 | Jennifer L. Callahan | Corporate Controller | Buy | $4K (4,000 @ $1.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.